author_facet Liu, C-T.
Chen, L-T.
Chen, Y-Y.
Chen, J-S.
Su, Y-L.
Chou, W-C.
Lu, C-H.
Ku, F-C.
Chen, M-H.
Shan, Y-S.
Liu, C-T.
Chen, L-T.
Chen, Y-Y.
Chen, J-S.
Su, Y-L.
Chou, W-C.
Lu, C-H.
Ku, F-C.
Chen, M-H.
Shan, Y-S.
author Liu, C-T.
Chen, L-T.
Chen, Y-Y.
Chen, J-S.
Su, Y-L.
Chou, W-C.
Lu, C-H.
Ku, F-C.
Chen, M-H.
Shan, Y-S.
spellingShingle Liu, C-T.
Chen, L-T.
Chen, Y-Y.
Chen, J-S.
Su, Y-L.
Chou, W-C.
Lu, C-H.
Ku, F-C.
Chen, M-H.
Shan, Y-S.
Annals of Oncology
420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
Oncology
Hematology
author_sort liu, c-t.
spelling Liu, C-T. Chen, L-T. Chen, Y-Y. Chen, J-S. Su, Y-L. Chou, W-C. Lu, C-H. Ku, F-C. Chen, M-H. Shan, Y-S. 0923-7534 1569-8041 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdw590.006 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan Annals of Oncology
doi_str_mv 10.1093/annonc/mdw590.006
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR3NTkwLjAwNg
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR3NTkwLjAwNg
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint Elsevier BV, 2016
imprint_str_mv Elsevier BV, 2016
issn 0923-7534
1569-8041
issn_str_mv 0923-7534
1569-8041
language English
mega_collection Elsevier BV (CrossRef)
match_str liu2016420psequentialuseofeverolimusandsunitinibintreatingwhograde1and2pancreaticneuroendocrinetumorsretrospectivemulticenterstudyintaiwan
publishDateSort 2016
publisher Elsevier BV
recordtype ai
record_format ai
series Annals of Oncology
source_id 49
title 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_unstemmed 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_full 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_fullStr 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_full_unstemmed 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_short 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_sort 420p sequential use of everolimus and sunitinib in treating who grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in taiwan
topic Oncology
Hematology
url http://dx.doi.org/10.1093/annonc/mdw590.006
publishDate 2016
physical
description
container_issue suppl_9
container_start_page 0
container_title Annals of Oncology
container_volume 27
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792320520034713616
geogr_code not assigned
last_indexed 2024-03-01T10:47:04.772Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=420P+Sequential+use+of+everolimus+and+sunitinib+in+treating+WHO+grade+1+and+2+pancreatic+neuroendocrine+tumors%E2%80%93retrospective+multi-center+study+in+Taiwan&rft.date=2016-12-01&genre=article&issn=1569-8041&volume=27&issue=suppl_9&jtitle=Annals+of+Oncology&atitle=420P+Sequential+use+of+everolimus+and+sunitinib+in+treating+WHO+grade+1+and+2+pancreatic+neuroendocrine+tumors%E2%80%93retrospective+multi-center+study+in+Taiwan&aulast=Shan&aufirst=Y-S.&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdw590.006&rft.language%5B0%5D=eng
SOLR
_version_ 1792320520034713616
author Liu, C-T., Chen, L-T., Chen, Y-Y., Chen, J-S., Su, Y-L., Chou, W-C., Lu, C-H., Ku, F-C., Chen, M-H., Shan, Y-S.
author_facet Liu, C-T., Chen, L-T., Chen, Y-Y., Chen, J-S., Su, Y-L., Chou, W-C., Lu, C-H., Ku, F-C., Chen, M-H., Shan, Y-S., Liu, C-T., Chen, L-T., Chen, Y-Y., Chen, J-S., Su, Y-L., Chou, W-C., Lu, C-H., Ku, F-C., Chen, M-H., Shan, Y-S.
author_sort liu, c-t.
container_issue suppl_9
container_start_page 0
container_title Annals of Oncology
container_volume 27
description
doi_str_mv 10.1093/annonc/mdw590.006
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR3NTkwLjAwNg
imprint Elsevier BV, 2016
imprint_str_mv Elsevier BV, 2016
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 0923-7534, 1569-8041
issn_str_mv 0923-7534, 1569-8041
language English
last_indexed 2024-03-01T10:47:04.772Z
match_str liu2016420psequentialuseofeverolimusandsunitinibintreatingwhograde1and2pancreaticneuroendocrinetumorsretrospectivemulticenterstudyintaiwan
mega_collection Elsevier BV (CrossRef)
physical
publishDate 2016
publishDateSort 2016
publisher Elsevier BV
record_format ai
recordtype ai
series Annals of Oncology
source_id 49
spelling Liu, C-T. Chen, L-T. Chen, Y-Y. Chen, J-S. Su, Y-L. Chou, W-C. Lu, C-H. Ku, F-C. Chen, M-H. Shan, Y-S. 0923-7534 1569-8041 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdw590.006 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan Annals of Oncology
spellingShingle Liu, C-T., Chen, L-T., Chen, Y-Y., Chen, J-S., Su, Y-L., Chou, W-C., Lu, C-H., Ku, F-C., Chen, M-H., Shan, Y-S., Annals of Oncology, 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan, Oncology, Hematology
title 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_full 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_fullStr 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_full_unstemmed 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_short 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
title_sort 420p sequential use of everolimus and sunitinib in treating who grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in taiwan
title_unstemmed 420P Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors–retrospective multi-center study in Taiwan
topic Oncology, Hematology
url http://dx.doi.org/10.1093/annonc/mdw590.006